Rethinking R&D productivity to promote sustainable growth

Even as pharma and life sciences organizations continue to follow a decades-long trend of increased R&D investments, the productivity of these investments has been declining. At the same time, conversations about the financial viability of pharmaceutical products continue to be taboo, potentially leading to inadvisable, expensive decisions. Watch this webinar with ZS’s Mukulita Bapat and Scott Sandford as they explore how organizations can balance the science, safety and long-term viability of pharma products by using a simple decision-making framework.

During this webinar, you will learn to:

Ready to get started?

Connect with an expert to find your next solution.
Get Started
/content/zs/en/contact-us-do-not-use
default
tagList
/content/zs/en/insights

/content/zs/en/insights

zs:topic/life-sciences-r&d-&-medical,zs:,zs:industry/life-sciences